Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Assets Average: 2019-2025

Historic Assets Average for Bicycle Therapeutics (BCYC) over the last 6 years, with Sep 2025 value amounting to $798.1 million.

  • Bicycle Therapeutics' Assets Average fell 22.30% to $798.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $798.1 million, marking a year-over-year decrease of 22.30%. This contributed to the annual value of $776.1 million for FY2024, which is 54.30% up from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Assets Average is $798.1 million, which was down 6.99% from $858.0 million recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' Assets Average peaked at $1.0 billion during Q3 2024, and registered a low of $192.5 million during Q1 2021.
  • Over the past 3 years, Bicycle Therapeutics' median Assets Average value was $798.1 million (recorded in 2025), while the average stood at $725.3 million.
  • In the last 5 years, Bicycle Therapeutics' Assets Average skyrocketed by 143.99% in 2022 and then declined by 22.30% in 2025.
  • Over the past 5 years, Bicycle Therapeutics' Assets Average (Quarterly) stood at $380.6 million in 2021, then grew by 8.75% to $413.9 million in 2022, then surged by 49.08% to $617.0 million in 2023, then spiked by 58.31% to $976.8 million in 2024, then dropped by 22.30% to $798.1 million in 2025.
  • Its Assets Average was $798.1 million in Q3 2025, compared to $858.0 million in Q2 2025 and $920.4 million in Q1 2025.